Vis enkel innførsel

dc.contributor.authorSlotved, Hans-Christian
dc.contributor.authorSheppard, Carmen L.
dc.contributor.authorDalby, Trine
dc.contributor.authorvan der Ende, Arie
dc.contributor.authorFry, Norman K.
dc.contributor.authorMorfeldt, Eva
dc.contributor.authorNyholm, Outi
dc.contributor.authorRokney, Assaf
dc.contributor.authorRon, Merav
dc.contributor.authorSiira, Lotta
dc.contributor.authorScott, Kevin J.
dc.contributor.authorSmith, Andrew
dc.contributor.authorThom, Louise
dc.contributor.authorToropainen, Maija
dc.contributor.authorVESTRHEIM, DIDRIK FRIMANN
dc.date.accessioned2017-12-14T08:42:37Z
dc.date.available2017-12-14T08:42:37Z
dc.date.created2017-12-13T14:40:36Z
dc.date.issued2017
dc.identifier.citationScientific Reports. 2017, 7 .
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/11250/2471433
dc.description.abstractAn external quality assessment (EQA) scheme for pneumococcal serotype identification has been performed over a period of 11 years, by a network of European pneumococcal reference laboratories. We report the results from the EQA, and present an assessment of the acceptability and utility of the EQA scheme. Reports from 22 EQA panels distributed in 2005-2016 were analysed. Each EQA panel consisted of seven isolates. A questionnaire including seven questions related to the acceptability and utility of the EQA scheme was distributed to all participating laboratories. Altogether, 154 pneumococcal isolates were tested. Of the 92 serologically distinct serotypes currently defined, 49 serotypes were included in the rounds. Discrepant results were observed in eight EQA rounds, involving 11 isolates (7.1%, 95% CI: 4% to 12%). All participating laboratories reported that the EQA scheme was useful for quality assurance purposes. Our results show that comparable serotyping data can be obtained in different laboratories. The EQA participation helps to keep the typing procedures at a high standard and provides data for accreditation purposes. The EQA is helpful when new technologies are introduced, and reveal limitations of both genotypic and phenotypic methods. Continuation of the presented EQA scheme is planned
dc.language.isoeng
dc.relation.urihttps://www.nature.com/articles/s41598-017-13605-8
dc.titleExternal Quality Assurance for Laboratory Identification and Capsular Typing of Streptococcus pneumoniae
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber10
dc.source.volume7
dc.source.journalScientific Reports
dc.identifier.doi10.1038/s41598-017-13605-8
dc.identifier.cristin1526909
cristin.unitcode7502,4,15,0
cristin.unitnameVaksineforebyggbare sykdommer
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel